FDA Inspection
Nuvo Pharmaceuticals Inc.Nuvo Pharmaceuticals Inc. – FDA Inspection, Sep 25, 2012
Record Details
This FDA Inspection record concerns Nuvo Pharmaceuticals Inc., with an inspection on September 25, 2012, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Nuvo Pharmaceuticals Inc.
- Inspection Date
- September 25, 2012
- Product Type
- Drugs
View Company Profile
ID · 67d380c7-f6a7-4329-b267-4089593d0fff
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 802626
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
2- 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Nuvo Pharmaceuticals Inc.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| July 26, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 12, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 28, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 24, 2009 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Nuvo Pharmaceuticals Inc.
- FDA Inspection 1068431 - 2018-07-26
- FDA Inspection 961931 - 2016-02-12
- FDA Inspection 823531 - 2013-02-28
- FDA Inspection 611552 - 2009-07-24
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.